Latest news
AbbVie (ABBV) Stock May Be 45% Below Fair Value As Rinvoq Expands In Europe - simplywall.stsimplywall.st · Sat, 08 Aug 2026 07:46:03 GMTThe Bull Case For AbbVie (ABBV) Could Change Following EU Approval Of Rinvoq For Vitiligo - webull.comwebull.com · Tue, 04 Aug 2026 08:36:41 GMTAbbVie: Skyrizi And Rinvoq Generate $8.03 Billion As Humira Revenue Falls 36% - Pulse 2.0Pulse 2.0 · Mon, 03 Aug 2026 03:49:28 GMTAbbVie Earnings: Can Skyrizi and Rinvoq Replace Humira? - CryptoDailyCryptoDaily · Fri, 31 Jul 2026 09:00:09 GMTABBV Q2 Deep Dive: Immunology and Neuroscience Expansion Shape Outlook Amid Guidance Reset - StockStoryStockStory · Fri, 31 Jul 2026 07:00:00 GMTAbbVie (ABBV) Stock: Rises as RINVOQ Wins EU Approval for Severe Hair Loss - BlockonomiBlockonomi · Wed, 29 Jul 2026 07:00:00 GMT